Metformin

Incident dementia risk among patients with type 2 diabetes receiving metformin versus alternative oral glucose-lowering therapy: an observational cohort study using UK primary healthcare records
William Doran, Louis Tunnicliffe, Rutendo Muzambi, Christopher T Rentsch, Krishnan Bhaskaran, Liam Smeeth, Carol Brayne, Dylan M Williams, Nish Chaturvedi, Sophie V Eastwood, Susanna J Dunachie, Rohini Mathur, Charlotte Warren-Gash

BMJ Open Diabetes Research and Care Jan 2024, 12 (1) e003548; DOI: 10.1136/bmjdrc-2023-003548
Major malformations risk following early pregnancy exposure to metformin: a systematic review and meta-analysis
Nazanin Abolhassani, Ursula Winterfeld, Yusuf C Kaplan, Cécile Jaques, Beatrice Minder Wyssmann, Cinzia Del Giovane, Alice Panchaud

BMJ Open Diabetes Research and Care Jan 2023, 11 (1) e002919; DOI: 10.1136/bmjdrc-2022-002919
Cord serum metabolome and birth weight in patients with gestational diabetes treated with metformin, insulin, or diet alone
Mikael S Huhtala, Tapani Rönnemaa, Outi Pellonperä, Kristiina Tertti

BMJ Open Diabetes Research and Care May 2021, 9 (1) e002022; DOI: 10.1136/bmjdrc-2020-002022
Use of metformin following a population-level intervention to encourage people with pre-diabetes to enroll in the National Diabetes Prevention Program
Thomas E Hurst, Laura N McEwen, Kevin L Joiner, William H Herman

BMJ Open Diabetes Research and Care Oct 2021, 9 (1) e002468; DOI: 10.1136/bmjdrc-2021-002468
Variables associated with increased incidence of non-alcoholic fatty liver disease (NAFLD) in patients with type 2 diabetes
Sven H Loosen, Münevver Demir, Anselm Kunstein, Markus Jördens, Natalia Qvarskhava, Mark Luedde, Tom Luedde, Christoph Roderburg, Karel Kostev

BMJ Open Diabetes Research and Care May 2021, 9 (1) e002243; DOI: 10.1136/bmjdrc-2021-002243
Secondary metformin monotherapy failure in individuals with type 2 diabetes mellitus
Tracey Weiss, Kristy Iglay, Tania Gulati, Swapnil Rajpathak, Lingfeng Yang, Lawrence Blonde

BMJ Open Diabetes Research and Care Jun 2021, 9 (1) e002127; DOI: 10.1136/bmjdrc-2021-002127
Safety of add-on sulfonylurea therapy in patients with type 2 diabetes using metformin: a population-based real-world study
Ingrid Hougen, Reid H Whitlock, Paul Komenda, Claudio Rigatto, Kristin K Clemens, Navdeep Tangri

BMJ Open Diabetes Research and Care Dec 2021, 9 (2) e002352; DOI: 10.1136/bmjdrc-2021-002352
Effects of metformin, acarbose, and sitagliptin monotherapy on gut microbiota in Zucker diabetic fatty rats
Minchun Zhang, Rilu Feng, Mei Yang, Cheng Qian, Zheng Wang, Wei Liu, Jing Ma

BMJ Open Diabetes Research and Care Sep 2019, 7 (1) e000717; DOI: 10.1136/bmjdrc-2019-000717
Treatment patterns and satisfaction in patients with type 2 diabetes newly initiating oral monotherapy with antidiabetic drugs in Japan: results from the prospective Real-world Observational Study on Patient Outcomes in Diabetes (RESPOND)
Atsushi Tajima, Keisuke Tobe, Jun-ichi Eiki, Hideki Origasa, Hirotaka Watada, Iichiro Shimomura, Shigeru Tokita, Takashi Kadowaki

BMJ Open Diabetes Research and Care Dec 2022, 10 (6) e003032; DOI: 10.1136/bmjdrc-2022-003032
Metformin in pregnancy and risk of abnormal growth outcomes at birth: a register-based cohort study
Kerstin MG Brand, Robyn Thoren, Jaak Sõnajalg, Emmanuelle Boutmy, Caroline Foch, Judith Schlachter, Katja M Hakkarainen, Laura Saarelainen

BMJ Open Diabetes Research and Care Dec 2022, 10 (6) e003056; DOI: 10.1136/bmjdrc-2022-003056

Main menu

Metformin

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Metformin

Pages